Release Date: 2023-09-14

Pathogenesis of Diabetes Mellitus

Release Date: 2023-09-14

The pathogenesis of diabetes mellitus involves complex mechanisms centered around insulin deficiency, resistance, or both. In type 1 diabetes mellitus (T1DM), an autoimmune destruction of pancreatic beta cells leads to insulin deficiency, resulting in hyperglycemia. Conversely, type 2 diabetes mellitus (T2DM) is characterized by insulin resistance in peripheral tissues, combined with impaired insulin secretion from [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page45
Last Page54
DOIhttps://doi.org/10.69860/nobel.9786053359111.5
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count10
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
The pathogenesis of diabetes mellitus involves complex mechanisms centered around insulin deficiency, resistance, or both. In type 1 diabetes mellitus (T1DM), an autoimmune destruction of pancreatic beta cells leads to insulin deficiency, resulting in hyperglycemia. Conversely, type 2 diabetes mellitus (T2DM) is characterized by insulin resistance in peripheral tissues, combined with impaired insulin secretion from pancreatic beta cells. Both genetic predisposition and environmental factors such as obesity and a sedentary lifestyle contribute to the development of T2DM. Additionally, gestational diabetes mellitus (GDM) occurs during pregnancy due to hormonal changes that increase insulin resistance. The pathophysiology of diabetes mellitus underscores the importance of insulin regulation and glucose metabolism in maintaining normal physiological function and highlights the diverse etiological factors involved in its development.
  • Kumar V, Abbas A, Aster J Robins and Cotran Pathologic Basis of Disease, Ninth Edition, 2015.

  • Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, … Todd JA. Remapping the insulin gene/ IDDM2 locus in type 1 diabetes. Diabetes.2004;53(7):1884-1889.

  • Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Immunobiology, 6th ed. London, UK: Garland Science, 2005.

  • Wildin RS, Freitas A. IPEX and FOXP3: clinical and research perspectives. Journal of Autoimmunity 2005; 25 (Supplement): 56–62.

  • Zatalia SR, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta medica Indonesiana. 2013;45(2):141–7.

  • Lynch J, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R, Salonen JT. Moderately intense physical activities and high levels of cardiorespiratory fi tness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med. 1996;156(12):1307-1314.

  • Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat. Med. 2017; 23: 804–814.

  • Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type2 diabetes mellitus. Am. J. Cardiol. 2002; 90: 11G–18G.

  • Petersen KF, Shulman GI. Cellular mechanism of insulin resistance in skeletal muscle. J.RSoc.Med.2002; 95 (Suppl. 42): 8–13.

  • Wamique M, Ali W. Rizvi Fatima Nishat. Role of free fatty acid and elevated VLDL in type II diabetes mellitus - a review. EJPMR. 2015;2(7):115–9.

  • Oh YS, Bae GD, Baek DJ, Park EY, Jun HS. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol. 2018;9(07):1–10.

  • Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014;7:587–91.

  • Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;4(03):1–12.

  • Han SJ, Boyko EJ. The evidence for an obesity paradox in type 2 diabetes mellitus. Diabetes Metab J. 2018;42(3):179–87.

  • Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3): 456–80.

Share This Chapter!